Selected Recent Cross-Border Transactions
in its agreement to be acquired by
Jan 2021
$4.6 billion
in its acquisition of
Jan 2021
€1.24 billion
in the sale of its commercial, clinical and research-stage oncology portfolio to
Dec 2020
$2 billion
in its acquisition by
Dec 2020
$39 billion
in its all-stock merger with
Nov 2020
$44 billion
in its Up-C transaction with its shareholders,
Nov 2020
in its acquisition of
Nov 2020
$2.75 billion
in its agreement to acquire
Nov 2020
$11.6 billion
in its acquisition by
Nov 2020
$1.35 billion
in the acquisition of Watford Holdings Ltd., by Arch Capital Group Ltd., Warburg Pincus and Kelso & Company
Nov 2020
$700 million
in its sale of a 34.9% stake in Scientific Games to institutional investors including Caledonia
Sep 2020
$1 billion
in the spin-off of its eye health business
Aug 2020